149 related articles for article (PubMed ID: 21039995)
21. Fanconi's anemia--chromosome breakage studies in homozygotes and heterozygotes.
Rosendorff J; Bernstein R
Cancer Genet Cytogenet; 1988 Jul; 33(2):175-83. PubMed ID: 3133104
[TBL] [Abstract][Full Text] [Related]
22. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact.
Castella M; Pujol R; Callén E; Ramírez MJ; Casado JA; Talavera M; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Estella J; Dasí Á; Rodríguez-Villa A; Gómez P; Tapia M; Molinés A; Figuera Á; Bueren JA; Surrallés J
J Med Genet; 2011 Apr; 48(4):242-50. PubMed ID: 21217111
[TBL] [Abstract][Full Text] [Related]
23. Influence of GSTT1, mEH, CYP2E1 and RAD51 polymorphisms on diepoxybutane-induced SCE frequency in cultured human lymphocytes.
Schlade-Bartusiak K; Rozik K; Laczmanska I; Ramsey D; Sasiadek M
Mutat Res; 2004 Mar; 558(1-2):121-30. PubMed ID: 15036125
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of acetyl-l-carnitine and α-lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes.
Ponte F; Carvalho F; Porto B
Toxicology; 2011 Oct; 289(1):52-8. PubMed ID: 21807063
[TBL] [Abstract][Full Text] [Related]
25. 1,2:3,4-Diepoxybutane Induces Multipolar Mitosis in Cultured Human Lymphocytes.
Barajas Torres RL; Domínguez Cruz MD; Borjas Gutiérrez C; Ramírez Dueñas Mde L; Magaña Torres MT; González García JR
Cytogenet Genome Res; 2016; 148(2-3):179-84. PubMed ID: 27193269
[TBL] [Abstract][Full Text] [Related]
26. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity.
Auerbach AD; Rogatko A; Schroeder-Kurth TM
Blood; 1989 Feb; 73(2):391-6. PubMed ID: 2917181
[TBL] [Abstract][Full Text] [Related]
27. DEB test for Fanconi anemia detection in patients with atypical phenotypes.
Esmer C; Sánchez S; Ramos S; Molina B; Frias S; Carnevale A
Am J Med Genet A; 2004 Jan; 124A(1):35-9. PubMed ID: 14679584
[TBL] [Abstract][Full Text] [Related]
28. Fanconi's anemia: a cytogenetic study on lymphocyte and bone marrow cultures utilizing 1,2:3,4-diepoxybutane.
Marx MP; Smith S; Heyns AD; van Tonder IZ
Cancer Genet Cytogenet; 1983 May; 9(1):51-9. PubMed ID: 6839306
[TBL] [Abstract][Full Text] [Related]
29. A novel diagnostic screen for defects in the Fanconi anemia pathway.
Shimamura A; Montes de Oca R; Svenson JL; Haining N; Moreau LA; Nathan DG; D'Andrea AD
Blood; 2002 Dec; 100(13):4649-54. PubMed ID: 12393398
[TBL] [Abstract][Full Text] [Related]
30. GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes.
Vlachodimitropoulos D; Norppa H; Autio K; Catalán J; Hirvonen A; Tasa G; Uusküla M; Demopoulos NA; Sorsa M
Mutagenesis; 1997 Sep; 12(5):397-403. PubMed ID: 9379921
[TBL] [Abstract][Full Text] [Related]
31. Preliminary communication: prenatal detection of the Fanconi Anemia gene by cytogenetic methods.
Auerbach AD; Warburton D; Bloom AD; Chaganti RS
Am J Hum Genet; 1979 Jan; 31(1):77-81. PubMed ID: 433924
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of Fanconi anemia from aplastic anemia by chromosomal breakage test.
Hou JW; Wang TR
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):121-6. PubMed ID: 9151465
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of fanconi anemia by diepoxybutane analysis.
Auerbach AD
Curr Protoc Hum Genet; 2003 Jul; Chapter 8():Unit 8.7. PubMed ID: 18428345
[TBL] [Abstract][Full Text] [Related]
34. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes.
Norppa H; Hirvonen A; Järventaus H; Uusküla M; Tasa G; Ojajärvi A; Sorsa M
Carcinogenesis; 1995 Jun; 16(6):1261-4. PubMed ID: 7788840
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation.
Mohseni-Meybodi A; Mozdarani H; Vosough P
Cytogenet Genome Res; 2007; 119(3-4):191-5. PubMed ID: 18253028
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals.
Gebhart E; Kysela D; Matthee H; Nikol M
Hum Genet; 1985; 69(4):309-15. PubMed ID: 3921453
[TBL] [Abstract][Full Text] [Related]
37. Failure of diepoxybutane to enhance sister chromatid exchange levels in Fanconi's anemia patients and heterozygotes.
Porfirio B; Dallapiccola B; Mokini V; Alimena G; Gandini E
Hum Genet; 1983; 63(2):117-20. PubMed ID: 6840755
[TBL] [Abstract][Full Text] [Related]
38. Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.
Porfirio B; Ambroso G; Giannella G; Isacchi G; Dallapiccola B
Hum Genet; 1989 Aug; 83(1):49-51. PubMed ID: 2767678
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes.
Murg Mn; Schuler M; Eastmond DA
Mutagenesis; 1999 Nov; 14(6):541-6. PubMed ID: 10567028
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cytogenetic effects of 3,4-epoxy-1-butene and 1,2:3, 4-diepoxybutane in mouse, rat and human lymphocytes following in vitro G0 exposures.
Kligerman AD; DeMarini DM; Doerr CL; Hanley NM; Milholland VS; Tennant AH
Mutat Res; 1999 Feb; 439(1):13-23. PubMed ID: 10029668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
